PQP: Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA product code PQP: Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System. View classification details, related manufacturers, 510(k) clearances, and recall records.
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
Device class
3
Regulation number
Not provided
Medical specialty
Unknown
Review panel
PA
FDA definition
A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope
0 clearance records and 18 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Dec 4, 2017 to Jun 10, 2026.
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.